Autor: "Ngan HY" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.
Autorzy:: Siu MK; Department of Pathology, The University of Hong Kong, Hong Kong, HKSAR, China; Department of Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong, HKSAR, China.
Kong DS; Department of Pathology, The University of Hong Kong, Hong Kong, HKSAR, China.
Ngai SY; Department of Pathology, The University of Hong Kong, Hong Kong, HKSAR, China.
Chan HY; Department of Pathology, The University of Hong Kong, Hong Kong, HKSAR, China.
Jiang L; Department of Pathology, The University of Hong Kong, Hong Kong, HKSAR, China.
Wong ES; Department of Pathology, The University of Hong Kong, Hong Kong, HKSAR, China.
Liu SS; Department of Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong, HKSAR, China.
Chan KK; Department of Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong, HKSAR, China.
Ngan HY; Department of Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong, HKSAR, China.
Cheung AN; Department of Pathology, The University of Hong Kong, Hong Kong, HKSAR, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Jul 28; Vol. 10 (7), pp. e0133467. Date of Electronic Publication: 2015 Jul 28 (Print Publication: 2015).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Endometrial Neoplasms/*metabolism
Endometrial Neoplasms/*pathology
p21-Activated Kinases/*metabolism
Adult ; Aged ; Aged, 80 and over ; Cell Line, Tumor ; Cell Proliferation ; Cytoplasm/metabolism ; Endometrial Neoplasms/mortality ; Female ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Phosphorylation ; Young Adult ; p21-Activated Kinases/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance.
Autorzy:: Zhao F; Department of Pathology, The University of Hong Kong, HKSAR, China; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Siu MK; Obstetrics and Gynaecology, The University of Hong Kong, HKSAR, China.
Jiang L; Department of Pathology, West China Hospital, Sichuang University, Chengdu, China.
Tam KF; Department of Pathology, The University of Hong Kong, HKSAR, China.
Ngan HY; Obstetrics and Gynaecology, The University of Hong Kong, HKSAR, China.
Le XF; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Texas, United States of America.
Wong OG; Department of Pathology, The University of Hong Kong, HKSAR, China.
Wong ES; Department of Pathology, The University of Hong Kong, HKSAR, China.
Gomes AR; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Bella L; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Khongkow P; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Lam EW; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Cheung AN; Department of Pathology, The University of Hong Kong, HKSAR, China; Department of Pathology, The University of Hong Kong -Shenzhen Hospital, Shenzhen, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2014 Nov 20; Vol. 9 (11), pp. e113478. Date of Electronic Publication: 2014 Nov 20 (Print Publication: 2014).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents, Phytogenic/*pharmacology
Apoptosis/*drug effects
Forkhead Transcription Factors/*metabolism
Ovarian Neoplasms/*pathology
Paclitaxel/*pharmacology
Antineoplastic Agents, Phytogenic/therapeutic use ; Cell Line, Tumor ; Cell Movement ; Disease-Free Survival ; Down-Regulation/drug effects ; Drug Resistance, Neoplasm ; Female ; Follow-Up Studies ; Forkhead Box Protein M1 ; Forkhead Transcription Factors/antagonists & inhibitors ; Forkhead Transcription Factors/genetics ; G2 Phase Cell Cycle Checkpoints ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Kinesins/genetics ; Neoplasm Staging ; Ovarian Neoplasms/diagnosis ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/mortality ; Paclitaxel/therapeutic use ; Prognosis ; Real-Time Polymerase Chain Reaction